Heart Failure Precision Medicine Study
Part of paid clinical trials in Sacramento, California.
- Sponsor
- University of California, Davis
- Study ID
- NCT04196842
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Telemonitoring devices — DEVICESet of telemonitoring devices: heart rate and blood pressure monitor, scale and activity tracker.
Study Details
The study aims to test the hypothesis that multi-omics studies can identify Heart Failure profiles at risk of adverse outcomes and evaluate a telemonitoring intervention in the optimization of guideline-directed medical therapy.
Key Dates
- Start date
- Oct 16, 2019
- Status verified
- Feb 2026
- Primary completion
- Oct 16, 2026
- Completion
- Oct 16, 2026
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: TelemonitoringBlood pressure and heart rate monitoring, scale, activity tracker.
- No Intervention: No interventionNo intervention.
Primary Outcome Measure
Rate of adverse outcomes in heart failure [ Time Frame: Five years from enrollment ]
Central Contacts
- Erick S Romero, MD(916) 703-2071
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| UC Davis Medical Center | Sacramento | California | 95817 |
Find similar trials in Sacramento, CA
By condition
By specialty
By research site
Related Studies
- Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy ProductsRecruiting · Medtronic · Birmingham, Alabama
- The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMRRecruiting · Cardiac Dimensions, Inc. · Gilbert, Arizona
- Transplant of Redeemed Organs by Judicious Administration of New Direct-Acting Antivirals for Hepatitis-C Heart RecipientsPHASE2 · Recruiting · Baylor Research Institute · Los Angeles, California
- Metformin for Pulmonary Hypertension HFpEFPHASE2 · Recruiting · University of California, San Francisco · San Francisco, California